热门资讯> 正文

Xenetic Biosciences报告第一季度业绩

2025-05-14 20:21

Xenetic Biosciences(XBIO) 0

Xenetic Biosciences press release (NASDAQ:XBIO): Q1 Net loss was approximately $0.9 million.
Revenue increased by approximately $0.1 million, or 16.1%, to approximately $0.6 million during the three months ended March 31, 2025 from approximately $0.5 million in the comparable quarter in 2024.
The Company ended the quarter with approximately $5.2 million of cash.

More on Xenetic Biosciences

Seeking Alpha’s Quant Rating on Xenetic Biosciences
Historical earnings data for Xenetic Biosciences
Financial information for Xenetic Biosciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。